financetom
Business
financetom
/
Business
/
Helen of Troy Faces Macro, Competitive Headwinds in Fiscal Q3 Results, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Helen of Troy Faces Macro, Competitive Headwinds in Fiscal Q3 Results, Oppenheimer Says
Jan 3, 2025 12:16 PM

02:54 PM EST, 01/03/2025 (MT Newswires) -- Helen of Troy's (HELE) is expected to report fiscal Q3 results on Wednesday, with analysts projecting persistent macroeconomic and competitive pressures to weigh on top-line performance, Oppenheimer said Friday in a note.

While the company's management has made strides in distribution, Oppenheimer notes these efforts may not yet suffice to spur a turnaround.

The company's Q3 sales guidance projects a 1% to 4.5% decline, and Oppenheimer believes meeting the lower end of this range is achievable. For Q3 earnings, the brokerage forecasts earnings per share of $2.51, slightly below the Street consensus of $2.60 and management's guidance of $2.51 to $2.71.

With topline headwinds expected to persist into early 2025, Oppenheimer said Helen of Troy could narrow its full-year EPS guidance "to the lower end of the range inclusive of modest accretion benefits related to the recently completed Olive & June acquisition."

Oppenheimer has a perform rating on the stock.

Price: 59.48, Change: -0.05, Percent Change: -0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others
Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others
Nov 27, 2024
07:49 AM EST, 11/27/2024 (MT Newswires) -- Brookfield Asset Management Ltd. ( BAM ) is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company's billionaire founding family said it won't support any new bid to take its namesake drug-maker private, Bloomberg reported earlier Wednesday. New York-based Brookfield decided to end months...
Parkland Renews Normal Course Issuer Bid
Parkland Renews Normal Course Issuer Bid
Nov 27, 2024
07:50 AM EST, 11/27/2024 (MT Newswires) -- Parkland (PKI.TO) on Wednesday said the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid (NCIB). The company may buy back up to 13.8 million shares from Dec. 1 for one year. Under its current NCIB, which terminates on Nov. 30, Parkland bought back 3.1 million shares at...
Top Premarket Gainers
Top Premarket Gainers
Nov 27, 2024
07:52 AM EST, 11/27/2024 (MT Newswires) -- Cyclerion Therapeutics ( CYCN ) shares surged 62% pre-bell Wednesday following a 6.2% loss in the previous session. Interactive Strength ( TRNR ) shares advanced 59% after the company said it received a notice from Nasdaq confirming that it regained compliance with the exchange's listing rules. Infobird ( IFBD ) shares rose 46%...
Canada Nickel Reports Second
Canada Nickel Reports Second "Significant" Nickel Sulfide Interval at Bannockburn Project in Ontario
Nov 27, 2024
07:52 AM EST, 11/27/2024 (MT Newswires) -- Canada Nickel ( CNIKF ) said on Wednesday that it intersected a second significant interval of net textured sulfide on its Bannockburn property in Ontario. The company reported a new net-textured sulphide interval of 9.2 meters within overall highly mineralized interval of 12.7 meters in hole BAN24-20. Canada Nickel ( CNIKF ) said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved